Orchestra BioMed Holdings (OBIO) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Orchestra BioMed Holdings (OBIO) Company Statistics | The Fly

Orchestra BioMed Holdings

· OBIO

Dashboard

Financials

Ratios

Valuation

Statistics

365.439 M

+2.30%

General

Market Cap: $365.44M
Enterprise Value: $422.75M
Shares Outstanding: 59,880,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 99.32%
Operating Margin: -181.36%
Net Profit Margin: -184.60%
FCF Margin: -184.83%
ROA: -51.02%
ROE: -125.93%
ROIC: -56.28%
Current Ratio: 8.26
Debt-to-Equity: 2.41
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 11.65
P/FCF: —
P/B: 12.66
EV/EBITDA: -7.40

Growth

Rev 1Y: —
Rev 1Y Fwd Est: -98.65%
Rev 3Y (CAGR): 111.62%
Rev 5Y (CAGR): 42.48%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR)

Income Statement (TTM)

Revenue: $31.98M
Gross Margin: 99.32%
Operating Expenses: $89.75M
Operating Income: -$57.99M
Net Profit: -$59.03M

Balance Sheet

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $20.47M
Working Capital: $97.77M
Total Assets: $115.7M
Net Debt: $50.29M
Total Liabilities: $86.28M
Total Equity: $29.42M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$58.32M
Cash Flow from Investing: -$69.29M
Cash Flow from Financing: $129.33M
Free Cash Flow: -$59.1M
Capital Expenditures: $781K